BANK ON THIS: Target This Nation for the Next Bumper Crop of Cannabis Profits!
From the summer onwards, 2019 has been a frustrating year for cannabis stock investors. Both stocks and ETFs have failed to produce the gains that retail investors were counting on – but there’s a good reason for that. The problem isn’t the cannabis market, but the location, and location is everything for nimble, successful market traders.
Canada was an absolute gold mine for marijuana stock investors five years ago, and there are still opportunities there but it’s not as easy as it used to be. The United States was ground zero for pot stock profits a couple of years ago, but prices have plateaued and the 10x and 20x returns are harder to come by today.
Enterprising investors need to start looking for the next hub of activity in cannabis – the one that will dominate 2020, which is what I’ve been researching throughout 2019. I’m already getting ready for an incredible year in weed stocks, and you’ll be amazed at my latest pick for record-breaking returns.
I’m focusing on a country that’s a pioneer in medical cannabis, but most people have no idea about this; Israel has allowed its adult citizens to use medical cannabis with a physician’s prescription since way back in 1973. This nation is the sleeping giant in the global cannabis community, with the potential to be like Canada but with even faster growth.
Courtesy: Isracann Corporate Presentation
The Hebrew University of Jerusalem has spearheaded leading-edge cannabis innovation and research with its studies on THC and CBD cannabinoid structure. Access to top researchers in the field provides Israel with valuable strategic data for the development of formulations and cannabinoid profiles – this country is clearly where you need to focus your next cannabis investment.
93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.
Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!
Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!
Not only does Israel have the world’s top researchers, but it has the ideal climate for cultivating cannabis – much better than Canada, in fact. 300 days of sunlight per year mean optimal sun exposure and reduced production costs, while perfect humidity levels make it much easier to safeguard the plant from insects and enable optimal growth.
Cannabis is currently legal for medical purposes in Israel and is decriminalized for recreational use, so you’ll want to start investing today in order to maximize your returns on this rare opportunity in a high-growth industry. The company that stands to gain the most from this is Isracann Biosciences (CSE: IPOT & US: ISCNF), which specializes in the ultra-low-cost production of high-quality medical cannabis for the undersupplied domestic Israeli market.
With more than 46,000 medical cannabis patients in Israel and an estimated 90,000 anticipated by 2020, Isracann is tapping into an underserved domestic market that presents significant and immediate opportunity for the market, the company, and investors who buy shares while they’re still easily affordable.
While everybody else is completely focused on the Canadian and American cannabis markets, I’m looking to Isracann as my ticket to wealth in the Israeli market, where conditions allow for super-efficient production at only around one-third of the cost of growing in colder climates like Canada.
In a country where literally 10,000 patients are on a waiting list to get medical cannabis from their pharmacists, the Israeli marijuana market is about to break wide open. Just imagine the profits that will be reaped when more investors catch on to this niche market.
Set your sights on Israel as tomorrow’s cannabis mecca and prepare yourself ahead of time with shares of Isracann (CSE: IPOT & OTC: ISCNF), which is the premier company in this ultimate hotspot of pot.
Chief Editor, CrushTheStreet.com
Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!
Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!
This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. Crush The Street has been compensated three hundred thousand dollars, directly by IsraCann Biosciences, for a marketing campaign. We have also participated in a private placement. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Please read our full disclaimer at CrushTheStreet.com/